FDA Inspection 1273417 — Xttrium Laboratories, Inc.
The FDA completed an inspection of Xttrium Laboratories, Inc. on Jun 18, 2025 in Mount Prospect, IL. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Jun 18, 2025
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Mount Prospect, IL (United States)